Literature DB >> 10864684

Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression.

Z Fu1, M J Cannon.   

Abstract

In contrast to the major role played by Epstein-Barr virus (EBV)-specific CD8(+) cytotoxic T-cell responses in immunosurveillance, recent studies have offered the apparently paradoxical suggestion that development of EBV-driven human B-cell lymphoproliferative disorders and tumors in SCID/hu mice is dependent on the presence of T cells, in particular CD4(+) T cells. This study presents a functional analysis of the CD4(+) T-cell response to EBV and shows that while CD4(+) T cells may be cytotoxic, they also express Th2 cytokines and CD40 ligand (gp39) and possess B-cell helper function. We show that EBV-specific CD4(+) T cells can provide non-HLA-restricted help for activation of resting B cells via a gp39-CD40-dependent pathway and are able to induce expression of BZLF1, a viral lytic cycle transactivator in latently infected resting B cells, ultimately resulting in rapid outgrowth of transformed B-cell colonies. These results support the proposal that CD4(+) T cells may play a key role in reactivation of latent EBV infection and may thus contribute to the pathogenesis of EBV-driven lymphoproliferative disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864684      PMCID: PMC112180          DOI: 10.1128/jvi.74.14.6675-6679.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Activity of transplanted CD8+ versus CD4+ cytotoxic T cells against Epstein-Barr virus-immortalized B cell tumors in SCID mice.

Authors:  S D Rencher; K S Slobod; F S Smith; J L Hurwitz
Journal:  Transplantation       Date:  1994-09-15       Impact factor: 4.939

2.  Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients.

Authors:  O M Martinez; J C Villanueva; L Lawrence-Miyasaki; M B Quinn; K Cox; S M Krams
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

3.  IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand.

Authors:  B G Cocks; R de Waal Malefyt; J P Galizzi; J E de Vries; G Aversa
Journal:  Int Immunol       Date:  1993-06       Impact factor: 4.823

4.  Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.

Authors:  S A Riddler; M C Breinig; J L McKnight
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

5.  Effects of cyclosporine on human B-cell lymphoma development in vivo.

Authors:  T J Boyle; R E Coles; A M Kizilbash; H K Lyerly
Journal:  Surg Oncol       Date:  1992-02       Impact factor: 3.279

Review 6.  Cytotoxic T lymphocyte responses to Epstein-Barr virus.

Authors:  A B Rickinson; S P Lee; N M Steven
Journal:  Curr Opin Immunol       Date:  1996-08       Impact factor: 7.486

7.  T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.

Authors:  R E Coles; T J Boyle; J M DiMaio; K R Berend; D F Via; H K Lyerly
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

Review 8.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09

9.  A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.

Authors:  F Chen; J Z Zou; L di Renzo; G Winberg; L F Hu; E Klein; G Klein; I Ernberg
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

10.  CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.

Authors:  M Faris; F Gaskin; J T Parsons; S M Fu
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  11 in total

1.  Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.

Authors:  A Douglas Wilson; Andrew J Morgan
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.

Authors:  Nancy H Gudgeon; Graham S Taylor; Heather M Long; Tracey A Haigh; Alan B Rickinson
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 3.  Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors.

Authors:  Shannon Kenney
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

4.  GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.

Authors:  R A Baiocchi; J S Ward; L Carrodeguas; C F Eisenbeis; R Peng; S Roychowdhury; S Vourganti; T Sekula; M O'Brien; M Moeschberger; M A Caligiuri
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 5.  Cytolytic CD4(+) T cells in viral immunity.

Authors:  Damien Z Soghoian; Hendrik Streeck
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

6.  In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors.

Authors:  A D Wilson; J C Hopkins; A J Morgan
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

7.  Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.

Authors:  Georgina J MacArthur; A Douglas Wilson; Martin A Birchall; Andrew J Morgan
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

8.  Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.

Authors:  Sarah Nikiforow; Kim Bottomly; George Miller; Christian Münz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells.

Authors:  Mikiko Kanamori; Shinya Watanabe; Reiko Honma; Masayuki Kuroda; Shosuke Imai; Kenzo Takada; Naoki Yamamoto; Yukihiro Nishiyama; Yasushi Kawaguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  CD4 T cell responses in latent and chronic viral infections.

Authors:  Senta Walton; Sanja Mandaric; Annette Oxenius
Journal:  Front Immunol       Date:  2013-05-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.